Surgical Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The surgical equipment market size is expected to grow from USD 19.81 billion in 2025 to USD 21.42 billion in 2026 and is forecast to reach USD 31.62 billion by 2031 at 8.13% CAGR over 2026-2031. This report is Segmented by Product (Handheld Surgical Instruments, Powered & Electrosurgical Devices, Sutures, and More), Application (Orthopedic & Trauma, Cardiovascular & Thoracic, and More), End User (Hospitals, Ambulatory Surgical Centers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Surgical Equipment Market Trends and Insights

Rising Surgical Procedure Volumes Driven by Aging & Chronic-Disease Prevalence

Procedure counts continue to climb, with roughly 235 million major operations performed each year. Orthopedic, cardiovascular, and oncology surgeries account for much of the incremental volume as global populations age and the burden of chronic disease rises. Manufacturers are responding by tailoring instruments to high-volume specialties rather than offering broad, general-purpose sets, improving throughput and reducing waste. Orthopedic procedures are growing 7.2% annually, spurring demand for powered saws, drills, and navigation aids. Cardiovascular interventions are advancing 5.8% per year, prompting investment in hybrid operating rooms that combine imaging and minimally invasive capabilities. The net effect is a sustained need for reliable, procedure-specific systems that can withstand heavy daily utilization.

Rising Number of Road and Other Accidents

Road-traffic injuries and workplace trauma continue to elevate demand for fracture fixation hardware, portable imaging, and navigation systems that enable rapid intervention in emergency settings. Beyond traditional plates and screws, trauma surgeons now seek integrated platforms capable of guiding screw placement in real time, shortening operative windows, and limiting repeat surgeries. Device makers have carved out a dedicated trauma segment within orthopedics, with growth outpacing general orthopedic equipment as hospitals expand major-injury centers and stock trauma-ready kits.

High Capital and Maintenance Costs of Advanced Surgical Systems

A top-tier robotic platform can cost more than USD 2 million, with annual service contracts adding 10-15%. Smaller hospitals and ASCs often defer purchases or seek pay-per-use models that link expenses to utilization. Leasing, profit-sharing, and risk-pooling agreements are gradually easing barriers, yet capital-intense systems remain concentrated in large academic centers.

Other drivers and restraints analyzed in the detailed report include:

• Accelerated Shift Toward Minimally Invasive & Robotic-Assisted Surgeries
• Growth of Ambulatory Surgical Centers and Outpatient Care Models
• Stringent Regulatory Approval & Compliance Requirements

Segment Analysis

Sutures, staplers, and other closure devices held 37.86% of the surgical equipment market share in 2025, underlining their universal role across specialties. Barbed sutures that eliminate knot-tying have shaved an average 1 minute 43 seconds off cesarean section closure times, demonstrating workflow value. Johnson & Johnson’s ECHELON ENDOPATH Staple Line Reinforcement illustrates how biomaterial advances can protect tissue and reduce leaks.

Powered and electrosurgical systems are projected to expand at an 8.45% CAGR through 2031. Instruments such as Medtronic’s LigaSure Maryland jaw blend cutting and vessel-sealing, cutting operative steps, and collateral damage. Retractors, handheld forceps, and surgical power tools remain essential staples, but the frontier lies in integrated consoles that merge energy, imaging, and smoke evacuation, streamlining the sterile field. The surgical equipment market size for powered devices is likely to gain further momentum as outpatient centers adopt multifunction towers for space efficiency.

Complete Report Scope:

• By Product
  • Handheld Surgical Instruments
    • Forceps & Graspers
    • Scalpels & Blades
    • Retractors & Dilators
  • Powered & Electrosurgical Devices
    • High-frequency Electrosurgery Units
    • Ultrasonic & Plasma Energy Systems
    • Surgical Power Tools
  • Sutures, Staplers & Wound Closure
    • Absorbable Sutures
    • Non-absorbable Sutures
    • Manual Staplers
    • Sealants & Tissue Adhesives
    • Others
• By Application
  • Orthopedic & Trauma
  • Cardiovascular & Thoracic
  • Obstetrics & Gynecology
  • Neurosurgery & Spine
  • Plastic, Cosmetic & Burn Reconstruction
  • Gastrointestinal & Bariatric
  • Other Surgeries
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics & Physician Offices
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 35.12% of 2025 revenue, driven by favorable reimbursement and early adoption of robotic and AI-enabled systems. Hospitals are under cost pressure, but ASCs are flourishing, reflecting payer incentives and patient preference for same-day procedures. Ongoing capital modernization delays have increased the average equipment life cycle, pushing providers toward service contracts and rental models. Nonetheless, U.S. and Canadian centers remain the proving ground for next-generation robotic and digital-surgery suites.

Europe presents a broad landscape anchored by robust public health systems. Germany, France, and the United Kingdom spearhead uptake of minimally invasive platforms. New Medical Device Regulations strengthen post-market oversight, raising compliance costs yet bolstering patient safety. Southern and Eastern European markets, upgrading legacy infrastructure, represent catch-up growth pockets where mid-priced, versatile instruments gain favor.

Asia-Pacific is the fastest-growing zone, advancing at an 8.69% CAGR through 2031. China is now the second-largest buyer of robotic theaters, supported by domestic manufacturers who tailor designs to local budgets. Japan leads in procedure volumes per capita, while India targets 15% annual device adoption via tax incentives and streamlined approvals. Southeast Asian nations are adding surgical suites in provincial hubs, fueling demand for turnkey, bundled equipment packages that include on-site training and service warranties.

The Middle East & Africa and South America offer long-range potential as governments allocate larger health budgets to surgical infrastructure. Private-sector hospital chains in Brazil and the Gulf Cooperation Council are early adopters of robotic systems, setting benchmarks that public facilities strive to match.

List of Companies Covered in this Report:

• Medtronic
• Johnson & Johnson
• Stryker
• B. Braun
• Olympus
• Boston Scientific
• Smiths Group
• Zimmer Biomet
• Conmed
• Intuitive Surgical
• Siemens Healthineers
• 3M
• Frankenman International Ltd.
• Meril Life Science
• Teleflex
• Karl Storz
• Arthrex
• Alcon
• Steris plc
• Surgical Holdings Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support